Found 9 matching trials
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy PHASE1 This is a two-part trial. "Solid tumor" in this protocol means solid tumor ...
Show More Learn More & Join Trial
Trial of Pimasertib in Hematological Malignancies PHASE2 This is an open-label, multi-center, dose-escalation trial of pimasertib (M...
Show More Location
Northwestern University
Learn More & Join Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors PHASE1 This research trial is testing a combination of two experimental drugs, MSC...
Show More Location
Pinnacle Oncology Hematology
Learn More & Join Trial
Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer PHASE2 This is a double blind, randomized, placebo-controlled, 2-arm, Phase 2 tria...
Show More Learn More & Join Trial
Trial of MSC1936369B in Subjects With Solid Tumors PHASE1 This is a first in man trial with a primary objective being the determinati...
Show More Location
Westmead Hospital
Learn More & Join Trial
Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer PHASE1 The research trial is testing the experimental treatment MSC1936369B in com...
Show More Location
For Recruiting Locations in the United States, please Contact U.S. Medical Information
Learn More & Join Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma PHASE2 This is a Phase 2, multicenter, randomized, controlled, open-label trial of...
Show More Learn More & Join Trial
Oral Bioavailability and Mass Balance Trial With Pimasertib PHASE1 This is a Phase 1, open-label, single centered trial to evaluate the mass b...
Show More Learn More & Join Trial
Relative Bioavailability of Pimasertib in Cancer Patients PHASE1 This is a Phase 1, multi-center, open-label, single-dose, 2 period, 2 seque...
Show More Location
Please Contact U.S. Medical Information Located in
Learn More & Join Trial